期刊文献+

左西孟旦治疗射血分数正常充血性心力衰竭患者的短期疗效 被引量:11

Short-term effects of levosimendan in patients with heart failure and normal ejection fraction
下载PDF
导出
摘要 目的:探讨左西孟旦治疗射血分数正常充血性心力衰竭(HFnEF)患者的短期疗效。方法:入选HFnEF患者80例,随机分为常规治疗组(血管紧张素转换酶抑制剂/血管紧张素受体阻断剂+利尿剂+硝酸酯类扩血管药)和左西孟旦组(常规治疗的基础上加用左西孟旦),每组各40例。所有患者于入院时和用药7 d后测定N末端B型利钠肽原(NT-proBNP)血浆水平、心功能分级、静息及分级小剂量多巴酚丁胺负荷后左室收缩功能指标:左室射血分数(LVEF)、高峰射血率(PER)、高峰射血时间(TPER),并计算其最大变化率。结果:治疗后两组NT-proBNP血浆水平均较治疗前明显下降,左西孟旦组治疗后NT-proBNP血浆水平低于常规治疗组治疗后(P<0.05);左西孟旦组显效率和总有效率高于常规治疗组,无效率低于常规治疗组(P<0.05);左西孟旦组治疗后LVEF、PER及TPER的最大变化率均较治疗前明显增加,且左西孟旦组治疗后LVEF的最大变化率明显高于常规治疗组(P<0.05)。结论:左西孟旦对HFnEF患者短期疗效良好,能降低患者血浆NT-proBNP水平,改善左心室收缩功能。 Objective:To investigate short-term effects of levosimendan in patients with heart failure and normal ejection fraction(HFnEF).Methods:A total of 80 patients with HFnEF were recruited and randomly devided into group A (conventional therapy only) and group B (levosimendan plus conventional therapy).The serum levels of N-terminal pro-B-type natriuretic peptide (NT proBNP),clinical efficacy and left ventricular systolic function indexes including left ventricular ejection fraction(LVEF),peak ejection rate(PER),peak ejection time(TPER) and its maximal change rate which were tested by radionuclide ventriculography at resting and dobutamine stress,were measured before and after treatment for 7 days.Results:Plasma NT-proBNP levels were significantly decreased after treatment in both groups(P<0.05).The degree of plasma NT-proBNP concentration in group B was decreased significantly compared to group A(P<0.05).Both significant effective rate and total effective rate in group B were higher than those in group A(P<0.05).The maximal change rate of LVEF,PER and TPER was significantly different before and after treatment in group B (P<0.05).After treatments the maximal change rate of LVEF in group B was higher than that in the group A (P<0.05).Conclusion:Short-term administratin of levosimendan can improve heart function of HFnEF patients by reducing plasma NT-proBNP.
出处 《国际心血管病杂志》 2014年第3期192-194,共3页 International Journal of Cardiovascular Disease
关键词 左西孟旦 N末端B型利钠肽原 射血分数正常心力衰竭 核素心室显像 Levosimendan N-teminal pro-B-type natriuretic peptide Heart failure with normal ejection fraction Radionuclide ventriculography
  • 相关文献

参考文献10

  • 1Dickstein K, (;ohen Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)[J]. Eur J Heart Fail, 2008,10(10) : 933-989.
  • 2Zhou J, Shi H, Zhang J, et al. Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) study [J ]. Eur J Heart Fail, 2010,12(2): 181-185.
  • 3OkMay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction[J]. Curr Heart Fail Rep,2013,10(4) : 401- 410.
  • 4Quiroz R, Doros G, Shaw P, et al. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort[J]. Am J Cardiol,2014,113(4) : 691-696.
  • 5Venskutonyte L, Molyte I, Ablonskyte-Dudoniene R, et al. Characteristic and management of acute heart failure patients in a single university hospital center[J]. Medicina(Kaunas), 2009, 45(11): 855- 870.
  • 6Bish K, Redfield MM. Acute heart failure with preserved eieetion fractionunique patient characteristics and targets for therapy[J]. Curr Heart FailRep, 2013, 10(3): 190- 197.
  • 7Penieka M, Vanderheyden M, Bartunek J. Diagnosis of heart failure with preserved ejection fraction:role of clinical Doppler echocardiography[J]. Heart, 2014, 100 ( l ) : 68-76.
  • 8Jorgensen K, Bech Hanssen O, Houltz E, et al. Effects of levosimendan on left ventrieular relaxation and early filling at maintainec preload and afterload conditions after aortic valve replacement for aortic stenosis [J]. Circulation, 2008, 117 (8): 1075 -1081.
  • 9Pathak A, Lebrin M, Vaecaro A, et al. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects[J]. J ClinPharmTher, 2013, 38(5): 341-349.
  • 10Nieminen MS, Fruhwald S, Heunks I,M, et al. Levosimendan: current data,clinical use and future development[J]. Heart Lung Vessel, 2013, 5(4) : 227 -245.

同被引文献123

  • 1徐筱跃.厄贝沙坦和卡托普利对社区老年心血管病患者左心室功能和心脏储备功能的影响[J].中国老年学杂志,2014,34(10):2871-2872. 被引量:8
  • 2杨跃进,尹栋,黄洁.心力衰竭的进展 (16)难治性心力衰竭的治疗原则和措施(续11)[J].中国循环杂志,2007,22(4):243-245. 被引量:7
  • 3Ji F,Li Z,Young N,et al.Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery[J].J Cardiothorac Vasc Anesth,2014,28(2):267-273.
  • 4Diegeler A,B?rgermann J,Kappert U,et al.Off-pump versus onpump coronary artery bypass grafting in elderly patients[J].N Engl J Med,2013,368(13):1189-1198.
  • 5Levin R,Degrange M,Del Mazo C,et al.Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass[J].Exp Clin Cardiol,2012,17(3):125-130.
  • 6De Hert SG,Lorsomradee S,Cromheecke S,et al.The effects of levosimendan in cardiac surgery patients with poor left ventricular function[J].Anesth Analg,2007,104(4):766-773.
  • 7Khan MU, Zhao W, Zhao T, et al, Nebivolol, a multifaceted antioxidant and cardioprotectant in hypertensive heart disease [J].] Cardiovasc Pharmaco1,2013,62(5) :445-451.
  • 8Uraizee I, Cheng S, Hung CL, et al, Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease [J]. Am] Hypertens , 2013, 26 (10): 1234-1241.
  • 9Hartupee r. Mann DL. Positioning of inflammatory biomarkers in the heart failure landscape [J].] Cardiovasc Transl Res,2013,6(4) :485-492.
  • 10Duran S, Duran r, Kaptanagas FA, et al. The role of pentraxin 3 as diagnostic value in classification of patients with heart failure[J]. Clin Biochem,2013 ,46( 12) :983-987.

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部